Team of IMAVITA is composed of the following people sharing the same vision
(in order of appearance since 2013):


Eric Lacoste Team Imavita Preclinical Efficacy CRO

Eric LACOSTE
CEO / CSO, Founder, DVM, DU Pharmacokinetics

Eric is a veterinarian from the National Veterinary School of Toulouse (ENVT) with a degree in pharmacokinetics / pharmcodynamics (DU: University Diploma). After his thesis (Molecular mechanisms of DNA virus-induced oncogenesis), he spent 2 years as Project manager at Hoechst Roussel Vet in Fortaleza, Brazil. From 1999 to 2008, he worked at Avogadro, France as Project Manager and during the last 4 years as Director of the Biochemistry/Biomarkers Laboratory. From 2009 to 2012, he was at the origin, founder and Chief Scientific Officer of Synelvia.
Eric brings his experience of laboratory, animal facilities management and his knowledge in biomarkers development and validation, PK/PD relationships, pre-clinical pathology models and pre-clinical imaging.


Bernard Jacquin Team Imavita Preclinical Efficacy CRO

Bernard JACQUIN
CFO, Founder

Bernard has an important career in financing of major and small companies in Americas. He brings his knowledge as senior in financing, accountability and strategical development.


Virginie Albinet Team Imavita Preclinical Efficacy CRO

Virginie ALBINET
PhD, Physiopathologist, Project Leader

Virginie is PhD graduated on 2012. She has spent 4 years at the laboratory of the Center of Oncology Research of Toulouse (Centre de Recherche en Cancérologie de Toulouse (CRCT) U1037 INSERM / UPS / CNRS) and has worked on the role of sphingosine 1-phosphate in melanoma-stroma interactions. She has joined the team in 2013.


Jeanne Chapel Team Imavita Preclinical Efficacy CRO

Jeanne CHAPEL
MSc, Research Scientist
Jeanne is graduated from University of Paul Sabatier, Toulouse, France (Master Bioingéniérie 2015). Jeanne works in the in vitro lab and helps in applications of in vivo models for drug efficacy evaluation and joined the team in 2017.


Claire AntoineTeam Imavita Preclinical Efficacy CRO

Claire ANTOINE
MSc, Research Scientist
Claire is graduated from University of Paul Sabatier, Toulouse, France (Master Toxicologie 2017). Claire works in the in vitro lab and helps in applications of in vivo models for drug efficacy evaluation.


Maud Chusseau Team Imavita Preclinical Efficacy CRO

Maud CHUSSEAU
MSc, Research Scientist
Maud is graduated from University of Claude Bernard, Lyon, France (Master Pharmacology / Animal experimentation 2007). Maud works in the in vitro lab and in vivo models for drug efficacy evaluation and has experience in qPCR, animals surgery and small animal imaging.


Julia Rochotte Team Imavita Preclinical Efficacy CRO

Julia ROCHOTTE
PhD, Immunologist, Project Leader

Julia is a young PhD graduated on 2014. She has spent 7 years at the laboratory of the Center of Oncology Research of Toulouse (Centre de Recherche en Cancérologie de Toulouse (CRCT) U1037 INSERM / UPS / CNRS) with an important background in immunology and immuno-oncology.


Claire COUSTAL
MSc Apprentice, Project Leader Assistant
Claire is actually graduating Master 2 (M2) Innovating Drug therapies and Biotherapeutics (“Biothérapies et Médicaments de Thérapie Innovante”) from University of Nantes, France.
Claire works now at Imavita in the in vitro lab and in vivo models for drug efficacy evaluation principally in the field of Osteo-Articular disease and Neurology/Neuro-Inflammation.


The team is completed by external competences (consulting / collaborations) in various fields:

Team Imavita Preclinical Efficacy CRO
Gravityscan Badge